Explore evidence

1.51 odds_ratioEarly sexual activity is associated with increased odds of HIV seropositivity in young women (OR = 1.510; 95% CI = 1.100, 2.072).

Burkina FasoVIH/sidapublished 2021Journal of global healthPubMeddocument of 4 observations

58.8 %The most common HIV-1 circulating recombinant forms and subtypes in Burkina Faso were CRF06_CPX (58.8%), CRF02_AG (35.3%), and subtype G (5.9%).

Burkina FasoVIH/sidapublished 2015Global health actioneurope_pmcdocument of 5 observations

2.21 %The overall seroprevalence rate of HIV among blood donors in Burkina Faso was 2.21%.

Burkina FasoVIH/sidapublished 2011Blood transfusion = Trasfusione del sangueeurope_pmcdocument of 9 observations

0.495 odds_ratioHIV stigma is negatively associated with HIV seropositivity in young women (OR = 0.495; 95% CI = 0.247, 0.990) in the fully adjusted model.

Burkina FasoVIH/sidapublished 2021Journal of global healthPubMeddocument of 4 observations

12.8 %The prevalence of HBV was 12.8% among HIV-1 seronegative subjects in the study population in Burkina Faso.

Burkina Fasohépatite B · VIH/sidapublished 2016BMC infectious diseaseseurope_pmcdocument of 4 observations

0 %Vertical transmission of HIV was 0.00% (0/274) among mothers under HAART.

Burkina FasoVIH/sidapublished 2015Global health actioneurope_pmcdocument of 5 observations

7.06 %L'incidence de la neuropathie périphérique était de 7,06 % chez les personnes vivant avec le VIH au Burkina Faso selon l'étude de Millogo A et al (2003).

Burkina FasoVIH/sidaobserved 2003HAL · Unilimdocument of 747 observations

5 %The prevalence of HIV drug resistance mutations (HIVDRM) is scored as low (≤ 5%) in all five study sites — Thailand, Vietnam, Burkina Faso, Côte d'Ivoire, and Senegal — for the three drug classes analyzed.

Burkina Faso · Côte d'Ivoire · SénégalVIH/sidapublished 2009AIDS Research and Human RetrovirusesOpenAlexdocument of 3 observations

8.4 %La fréquence de la neuropathie sensitive, sensitivo-motrice et polyneuropathique chez les personnes vivant avec le VIH au Burkina Faso était de 8,4 % en 2008.

Burkina Fasoneuropathie périphérique · VIH/sidaobserved 2008HAL · Unilimdocument of 747 observations

90 %La fréquence de la neuropathie chez les personnes vivant avec le VIH au Burkina Faso était de 90 % en 2007.

Burkina FasoVIH/sidaobserved 2007HAL · Unilimdocument of 747 observations

3.3 %Among 4,520 blood donors in Burkina Faso in 2009, 149 (3.30%) had serological evidence of multiple infections.

Burkina Fasohépatite B · hépatite C · syphilis · VIH/sidaobserved 2009published 2011Blood transfusion = Trasfusione del sangueeurope_pmcdocument of 9 observations

0.54 odds_ratioThe haplotype GGT from the rs6001417, rs8177832 and rs35228531 SNPs has a protective effect against HIV-1 infection with an odds ratio of 0.54 [0.43–0.68] and p-value < 0.001.

Burkina FasoVIH/sidapublished 2016PloS oneeurope_pmcdocument of 4 observations

1.6 odds_ratioThe haplotype GGC is associated with increased risk of HIV-1 infection with an odds ratio of 1.6 [1.1–2.3] and p-value < 0.05.

Burkina FasoVIH/sidapublished 2016PloS oneeurope_pmcdocument of 4 observations

56.7 %The prevalence of HBV was 56.7% among HIV-1 positive patients in the study population in Burkina Faso.

Burkina Fasohépatite B · VIH/sidapublished 2016BMC infectious diseaseseurope_pmcdocument of 4 observations

1.75 %Vertical transmission of HIV was 1.75% (2/114) among mothers under prophylaxis.

Burkina FasoVIH/sidapublished 2015Global health actioneurope_pmcdocument of 5 observations

0.52 %There was 0.52% (2/388) overall vertical transmission of HIV in infants born to HIV-positive mothers.

Burkina FasoVIH/sidapublished 2015Global health actioneurope_pmcdocument of 5 observations

1.8 %The seroprevalence of HIV in first-time volunteer blood donors in Burkina Faso in 2009 was 1.8%.

Burkina FasoVIH/sidaobserved 2009published 2012Tropical medicine & international health : TM & IHeurope_pmcdocument of 9 observationsDOI 10.1111/j.1365-3156.2011.02902.x

0.215 odds_ratioHigher education is associated with reduced odds of HIV seropositivity in young women (OR = 0.215; 95% CI = 0.057, 0.820).

Burkina FasoVIH/sidapublished 2021Journal of global healthPubMeddocument of 4 observations

3,270.2 per_100000Among 3,981 repeat blood donors in Burkina Faso in 2009, the incidence rate of anti-HIV-1 was 3270.2 per 100000 donations.

Burkina FasoVIH/sidaobserved 2009published 2012Tropical medicine & international health : TM & IHeurope_pmcdocument of 9 observationsDOI 10.1111/j.1365-3156.2011.02902.x

29.82 %Among 4,520 blood donors in Burkina Faso in 2009, 1,348 (29.82%) were infected with at least one pathogen.

Burkina Fasohépatite B · hépatite C · syphilis · VIH/sidaobserved 2009published 2011Blood transfusion = Trasfusione del sangueeurope_pmcdocument of 9 observations

The prevalence of HIV seropositivity among young women is higher than for men of the same age in all included Demographic and Health Surveys except for the Burkina Faso DHS.

Burkina FasoVIH/sidapublished 2021Journal of global healthPubMeddocument of 4 observations

8.4 %La fréquence de la neuropathie périphérique était de 8,4 % chez les personnes vivant avec le VIH au Burkina Faso selon l'étude de Millogo A et al (2008).

Burkina FasoVIH/sidaobserved 2008HAL · Unilimdocument of 747 observations

12.26 %In this study, 12.26% (394/3,215) of the pregnant women were diagnosed HIV positive.

Burkina FasoVIH/sidapublished 2015Global health actioneurope_pmcdocument of 5 observations

0.7 %The HIV prevalence rate is 0.7% in Burkina Faso.

Burkina FasoVIH/sidaHAL · Unilimdocument of 97 observations

5.21 odds_ratioThe haplotype CGC is associated with increased risk of HIV-1 infection with an odds ratio of 5.21 [2.4–11.3] and p-value < 0.001.

Burkina FasoVIH/sidapublished 2016PloS oneeurope_pmcdocument of 4 observations